Pitcairn CO Biogen Inc. Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Biogen Inc. stock. As of the latest transaction made, Pitcairn CO holds 1,099 shares of BIIB stock, worth $163,772. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,099

Previous 1,416 22.39%

Holding current value

$163,772

Previous $328,000 35.06%

% of portfolio

0.01%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$189.07 - $236.8 $59,935 - $75,065	-317 Reduced 22.39%	1,099 $213,000
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $33,341 - $41,426	-175 Reduced 11.0%	1,416 $328,000
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $12,933 - $16,330	-61 Reduced 3.69%	1,591 $343,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $12,242 - $14,736	-55 Reduced 3.22%	1,652 $427,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $13,424 - $15,152	53 Added 3.2%	1,707 $438,000
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $3,853 - $4,452	-14 Reduced 0.84%	1,654 $471,000
Q1 2023 May 05, 2023	SELL	$256.56 - $292.34 $7,696 - $8,770	-30 Reduced 1.77%	1,668 $463,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $252 - $306	1 Added 0.06%	1,698 $470,000
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $263,026 - $362,689	-1,351 Reduced 44.32%	1,697 $453,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $33,007 - $39,251	-176 Reduced 5.46%	3,048 $622,000
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $119,749 - $150,878	-618 Reduced 16.09%	3,224 $679,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $912,921 - $1.17 Million	-4,077 Reduced 51.48%	3,842 $922,000
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $187,622 - $244,680	663 Added 9.14%	7,919 $2.24 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $286,713 - $459,083	-1,107 Reduced 13.24%	7,256 $2.51 Million
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $116,616 - $136,622	-480 Reduced 5.43%	8,363 $2.34 Million
Q4 2020 Feb 05, 2021	BUY	$236.26 - $355.63 $498,508 - $750,379	2,110 Added 31.34%	8,843 $2.17 Million
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $474,997 - $548,443	1,794 Added 36.32%	6,733 $1.91 Million
Q2 2020 Jul 28, 2020	BUY	$258.66 - $342.55 $693,208 - $918,034	2,680 Added 118.64%	4,939 $1.32 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $83,612 - $106,063	311 Added 15.97%	2,259 $715,000
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $367,500 - $507,796	-1,670 Reduced 46.16%	1,948 $578,000
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $49,358 - $55,360	227 Added 6.69%	3,618 $842,000
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $12,280 - $13,536	-56 Reduced 1.62%	3,391 $793,000
Q1 2019 May 07, 2019	SELL	$216.71 - $338.96 $40,308 - $63,046	-186 Reduced 5.12%	3,447 $815,000
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $62,105 - $78,663	-223 Reduced 5.78%	3,633 $1.09 Million
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $46,081 - $60,261	-157 Reduced 3.91%	3,856 $1.36 Million
Q2 2018 Aug 02, 2018	SELL	$257.52 - $306.91 $60,774 - $72,430	-236 Reduced 5.55%	4,013 $1.17 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $68,674 - $97,128	-264 Reduced 5.85%	4,249 $1.16 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $21,534 - $24,120	-70 Reduced 1.53%	4,513 $1.44 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $1.29 Million - $1.51 Million	4,583	4,583 $1.44 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account